Diagonal Bio is trading at 0.0145 as of the 20th of March 2025, a 2.84 percent increase since the beginning of the trading day. The stock's open price was 0.0141. Diagonal Bio has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Although Diagonal Bio's alpha and beta are two of the key measurements used to evaluate Diagonal Bio's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Diagonal Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Content Syndication Now
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Elected by the shareholders, the Diagonal Bio's board of directors comprises two types of representatives: Diagonal Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagonal. The board's role is to monitor Diagonal Bio's management team and ensure that shareholders' interests are well served. Diagonal Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagonal Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Diagonal Bio financial ratios help investors to determine whether Diagonal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagonal with respect to the benefits of owning Diagonal Bio security.